Scottish Medicines Consortium seeks role in new UK value-based pricing system
This article was originally published in Scrip
Executive Summary
The Scottish Medicines Consortium (SMC), the health technology assessment body for Scotland, could have a role to play in value based pricing, which the UK coalition government says will replace the current Pharmaceutical Pricing and Reimbursement Scheme (PPRS) in 2014.